Why sex matters: the biological mechanisms of cardiovascular disease

Area of Science:

• Cardiovascular Medicine
• Women's Health
• Endocrinology

Background:

• Cardiovascular disease (CVD) is the primary cause of death and illness in women globally.
• Significant gaps exist in understanding the fundamental and clinical aspects of CVD specifically in women.
• Sexual dimorphism in CVD is well-documented in both human and animal studies.

Purpose of the Study:

• To review the pathophysiology of CVD in women.
• To explore potential clinical implications, focusing on biochemical markers and indicators of cardiovascular dysfunction.
• To highlight the need for sex-specific diagnostic, preventive, and treatment strategies for female patients.

Main Methods:

• Literature review focusing on CVD pathophysiology in women.
• Analysis of existing research on sexual dimorphism in cardiovascular health.
• Examination of biochemical markers and cardiovascular dysfunction indicators relevant to women.

Main Results:

• Menopause is a significant CVD risk factor in women, linked to reduced estrogen, though mechanisms require further elucidation.
• Estrogen's role in cardiovascular health involves both genomic and non-genomic pathways.
• Biochemical markers and indicators of cardiovascular damage are crucial for assessing CVD risk and progression in women.

Conclusions:

• Improved understanding of CVD pathophysiology in women is essential for advancing diagnostic and clinical strategies.
• Development of sex-specific prevention and treatment plans is critical for improving outcomes in female patients.
• Further research is needed to identify women who would benefit most from early CVD intervention.